Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cornisol

K-Number: K221759 · 2022-10-05

ApplicantAurolab
Decision Date2022-10-05
Product CodeLYX
DecisionSubstantially Equivalent

Device Summary

Cornisol is the device name listed in this FDA 510(k) record. The listed applicant is Aurolab. It received FDA 510(k) clearance on 2022-10-05 under 510(k) number K221759. The device is classified under product code LYX. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cornisol?

Cornisol is a medical device that received FDA 510(k) clearance on 2022-10-05. The listed applicant is Aurolab. The 510(k) number is K221759.

When did Cornisol receive FDA 510(k) clearance?

Cornisol received FDA 510(k) clearance on 2022-10-05, under 510(k) number K221759.

Who is the listed applicant for Cornisol?

The FDA 510(k) record lists Aurolab as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Cornisol?

The FDA product code for Cornisol is LYX.

Related Devices (Code: LYX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.